JD Health International stock
Price history
−52.06% over the period1 year: from $68.00 (November 20, 2025) to $32.60 (November 20, 2026), −52.06%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $32.60 |
| October 30, 2026 | $38.10 |
| September 30, 2026 | $36.00 |
| August 31, 2026 | $36.50 |
| July 31, 2026 | $39.40 |
| June 30, 2026 | $32.84 |
| May 29, 2026 | $38.40 |
| April 30, 2026 | $45.36 |
| March 31, 2026 | $47.06 |
| February 27, 2026 | $56.75 |
| January 30, 2026 | $63.25 |
| December 31, 2025 | $55.55 |
| November 28, 2025 | $61.10 |
| November 20, 2025 | $68.00 |
At a glance
The company
Operates an online healthcare platform in China offering medical consultations, health check-ups, home care services, medical devices and pharmaceutical products
Latest results
Quarter to June 30, 2026 · EPS ¥1.07
TickerLandia's take on JD Health International
- Cheaper than similar companies: trailing 12-month P/E 15 vs 23 (−34%) in a group of 10.
- Strong point: Financial strength (96/100 in its group). Weak point: Earnings stability (21/100).
- “Most upside for analysts” (Hong Kong): No. 4 of 91.
- “Beaten down but solid” (Hong Kong): No. 9 of 28.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−54.53% from the 52-week high
Analysts · 17 analysts
Average target$64.11+96.65% vs. price
Buy 16 · Hold 1 · Sell 0 · Strong buy
TickerLandia Fingerprint: JD Health International
Compared with similar companies: very high financial strength.
Financials and price compared with 130 companies in related industries (retail), worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Pricelow34
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 15.0 31 Forward P/E 11.3 21 EV/EBITDA 10.8 37 Price/book 1.43 22 Price/sales 1.32 62 Profitabilitylow38
How much it earns on revenue and capital.
Metric Value Position in group Net margin 7.9% 67 Gross margin 25.3% 28 Operating margin 6.1% 43 ROE 10.4% 25 ROA 3.7% 25 Earnings stabilitylow21
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 3.6% 23 Loss-making yearscounts in reverse: lower means more earnings stability 1 of 5 annual reports 18 Growthhigh79
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +15.90% 82 Earnings growth (year over year) +32.10% 72 Average revenue growth (3 years) +16.26% 82 Financial strengthvery high96
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 342.2 97 Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −7.84 100 Debt/equitycounts in reverse: lower means more financial strength 0.01 96 Current ratio 2.69 91 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumweak28
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −1.73% 45 Relative strength (6 months) −7.59% 38 Distance from 200-day average −23.08% 27 1-year return −52.06% 3 Riskhigh77
How much the price swings.
Metric Value Position in group Volatility (60 days) 49.9% 71 Beta (1 year) 1.50 81 Maximum drawdown (12 months) 54.1% 79
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
JD Health International is cheaper than similar companies
JD Health International's P/E (trailing 12 months): 15.0, −34% against the median of a group of 10 similar companies (22.8).
Compared with 10 similar companies
| Metric | JD Health International | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 15.0 | Low | |
| Forward P/E | 11.3 | Low | |
| Operating margin | 6.1% | Middle | |
| ROE | 10.4% | Low | |
| Debt/equity | 0.01 | Low |
Grey band: the middle half of the group; tick: the median; dot: JD Health International. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥40.89B
Latest quarter · Q2 2026
Net income
¥3.44B
Latest quarter · Q2 2026
Quarterly net margin
8.4%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $103.98B
- P/E
- 15.0
- EPS
- $2.17
- Volume
- 18.52M
- Daily trading
- €59.44M
- Dividend yield
- 0.00%
How JD Health International is changing
All resultsRevenue grew 30.5% a year on average over the last 5 years
Operating margin rose from −0.3% to 5.2%
Profits turn into cash: free cash flow equal to 161% of net income
Returns
JD Health International returns
$1,000 invested in JD Health International 5 years ago, on November 22, 2021, would be worth $464 today: −53.59% in total, −14.25% per year. This is the price return only: dividends are excluded.
| Period | JD Health International | Hang Seng | $1,000 becomes |
|---|---|---|---|
| 1 month | −18.09% | −6.10% | $819 |
| 6 months | −19.27% | −12.63% | $807 |
| Year to date | −41.31% | −12.56% | $587 |
| 1 year | −52.06% | −13.26% | $479 |
| 3 years | −18.30% | +26.06% | $817 |
| 5 years | −53.59% | −10.18% | $464 |
Over the last 6 months it has done better than 25% of the stocks in the Consumer sector.
Price only, without dividends. Calculate your investment
The chart in detail
JD Health International: technical analysis
JD Health International is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 83.3% below its all-time closing high ($195.00, December 23, 2020).
- Trend
- Downward
- RSI (14 sessions)
- 30
- Below 30: a strong fall in a short time
- vs 200-session average
- −23.08%
Active signals
RSI below 30: the stock has fallen a lot in a short time.
since November 19, 2026
Support and resistance
Price areas where JD Health International has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$37.45+14.89%3 touches, last on September 29, 2026
- Resistance$35.50+8.88%4 touches, last on October 29, 2026
- Resistance$33.44+2.58%2 touches, last on October 2, 2026
- Last price$32.60
- No support below: the price is near the lows of the year
Volatility and risk
Over the last year it has moved more than the Hang Seng.
- Beta (1 year) vs Hang Seng
- 1.50
- Volatility (60 sessions, annualised)
- 49.9%
- Largest fall in the last year
- −54.08%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
JD Health International: seasonality
Average monthly price change over 6 years
Over the last 6 years, the strongest month for JD Health International has been November: +12.86% on average, positive in 4 years out of 5. The weakest has been March: −9.61% on average, positive in 1 years out of 6.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −2.24% | +1.65% | 4 of 6 |
| February | −2.97% | −7.11% | 2 of 6 |
| March | −9.61% | −11.99% | 1 of 6 |
| April | +2.71% | +1.55% | 3 of 6 |
| May | −6.81% | −8.95% | 1 of 6 |
| June | +1.22% | +4.79% | 4 of 6 |
| July | +4.13% | +8.10% | 4 of 6 |
| August | −3.44% | −7.76% | 2 of 6 |
| September | +5.92% | +1.25% | 3 of 6 |
| October | −8.12% | −8.49% | 1 of 6 |
| November | +12.86% | +1.98% | 4 of 5 |
| December | −1.76% | −0.35% | 2 of 5 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
JD Health International and its competitors
JD Health International Inc. builds its activities around internet healthcare in China, combining online medical consultation, hospital and doctor referrals, health check-ups and genetic testing with home care such as wound care, blood tests and post-operative care. Its device range includes smart monitoring and respiratory therapy equipment, blood glucose meters, oxygen generators and rapid testing products. Pharmaceutical and healthcare goods reach consumers through direct sales, an online marketplace and on-demand retail, while advertisers and pharmaceutical and healthcare product companies form the other groups of customers.
- Headquarters
- Beijing, China
- Employees
- 6,018
- Founded
- 2014
- Chief executive
- Cao Dong
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| JD Health International6618 | $13.26B | 6.1% | 15.0 | −19.27% |
| Alibaba Health Information Tech0241 | $5.4B | 5.3% | 20.1 | −33.12% |
| Raia DrogasilRADL3 | $4.04B | 6.1% | 17.6 | −24.57% |
| Redcare PharmacyRDC | $1.47B | 0.3% | — | +36.52% |
| SHEIN Global Holdings0625 | $15.42B | 2.7% | 7.10 | — |
| Taiwan Mobile3045 | $11.4B | 11.6% | 22.7 | +6.96% |
Same industry or related industries, similar size. Compare JD Health International with its competitors · Full profile
